Post-op Ketamine Study

Rothman Institute Orthopaedics75 enrolled

Overview

The purpose of this study is to establish the effect of sub-anesthetic dosing of ketamine with spinal anesthesia during total knee arthroplasty on post-operative pain and narcotic consumption. We hypothesize that sub-anesthetic ketamine will decrease post-operative pain and narcotic consumption and may secondarily lead to shorter lengths of stay, faster rehabilitation, improved postoperative outcomes and patient satisfaction.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

QUADRUPLE

Enrollment

Conditions

Osteo Arthritis Knee

Interventions

Isotonic salineDRUG

Placebo

Ketamine Injectable SolutionDRUG

Active comparator

Eligibility

Medical Language ↔ Plain English

Inclusion Criteria: * 18 - 85 years of age * ASA I - IV * Undergoing primary unilateral elective total knee arthroplasty with spinal anesthesia Exclusion Criteria: * BMI over 40\* * Contraindication or allergy to opioid pain medication or ketamine\* * Daily opioid use for pain control before surgery in excess of systemic morphine equivalent to 10 mg\* * Ejection fraction (EF) less than 30% * Creatinine clearance less than 30 mL/min\* * History of chronic liver failure * Desire for nerve block or general anesthesia * Any neurologic or psychiatric disorder (including bipolar disorder, post traumatic stress disorder, schizophrenia) * Prior surgery on ipsilateral knee within the last 6 months * Alcohol abuse

Locations (1)

Rothman Institute

Philadelphia, Pennsylvania, United States

Outcomes

Primary Outcomes

Pain as reported on Visual Analog Scale

VAS pain reported 0-100mm

Time frame: Up to 6 weeks post-operatively

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.